Reaction Details |
| Report a problem with these data |
Target | Tyrosine-protein kinase transforming protein Abl |
---|
Ligand | BDBM3022 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Kinase Inhibition Assay |
---|
IC50 | 3760±n/a nM |
---|
Citation | Traxler, P; Bold, G; Frei, J; Lang, M; Lydon, N; Mett, H; Buchdunger, E; Meyer, T; Mueller, M; Furet, P Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines. J Med Chem40:3601-16 (1997) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Tyrosine-protein kinase transforming protein Abl |
---|
Name: | Tyrosine-protein kinase transforming protein Abl |
Synonyms: | ABL | ABL_MLVAB | Tyrosine-protein kinase V-ABL |
Type: | Enzyme |
Mol. Mass.: | 81895.89 |
Organism: | Abelson murine leukemia virus |
Description: | P00521 |
Residue: | 746 |
Sequence: | YITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHY
RINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDK
WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK
HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL
EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN
KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA
CWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGTRGGAGSMLQAPELPTKTRT
CRRAAEQKASPPSLTPKLLRRQVTASPSSGLSHKKEATKGSASGMGTPATAEPAPPSNKV
GLSKASSEEMRVRRHKHSSESPGRDKGRLAKLKPAPPPPPACTGKAGKPAQSPSQEAGEA
GGPTKTKCTSLAMDAVNTDPTKAGPPGEGLRKPVPPSVPKPQSTAKPPGTPTSPVSTPST
APAPSPLAGDQQPSSAAFIPLISTRVSLRKTRQPPERIASGTITKGVVLDSTEALCLAIS
RNSEQMASHSAVLEAGKNLYTFCVSYVDSIQQMRNKFAFREAINKLESNLRELQICPATA
SSGPAATQDFSKLLSSVKEISDIVRR
|
|
|
BDBM3022 |
---|
n/a |
---|
Name | BDBM3022 |
Synonyms: | 4-(Phenylamino)pyrazolo[3,4-d]pyrimidine deriv. 23 | N-(3-chlorophenyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
Type | Small organic molecule |
Emp. Form. | C17H12ClN5 |
Mol. Mass. | 321.764 |
SMILES | Clc1cccc(Nc2ncnc3n[nH]c(-c4ccccc4)c23)c1 |
Structure |
|